[Form 4] Accenture plc Insider Trading Activity

Rhea-AI Filing Summary

Accenture plc (ACN) Chief Leadership & HR Officer Katherine Lee Clifford reported a personal purchase of 66 Class A ordinary shares on 10/05/2025 at a price of $244.56 per share under the Accenture Voluntary Equity Investment Program. After the transaction she beneficially owns 4,821 shares, held directly. The Form 4 was signed by an attorney-in-fact on 10/06/2025. The filing notes the purchase was executed through the company program rather than an open-market trade, and it reflects a routine equity-plan contribution by an officer rather than a derivative or disposition.

Insights

Insider Transactions & Governance Analyst

Officer purchased a small block of shares via the company equity plan.

The transaction shows Katherine Lee Clifford, an officer, acquired 66 Class A shares at $244.56 under the Accenture Voluntary Equity Investment Program on 10/05/2025, increasing her direct holdings to 4,821 shares. This is a straightforward equity-plan purchase rather than a sale or option exercise.

The primary dependency is the internal plan mechanics; purchases under such programs are typically automated and scheduled. Investors should note the purchase size is modest relative to typical officer ownership levels, and there is no indication of a derivative position or disposition here. Expect no immediate governance implications; future filings would show any material change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clifford Katherine Lee

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Leadership & HR Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	10/05/2025		A		66(1)	A	$244.56	4,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Purchase of Accenture plc Class A ordinary shares from Accenture pursuant to the Accenture Voluntary Equity Investment Program.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Katherine Lee Clifford	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Accenture (ACN) officer Katherine Lee Clifford buy on 10/05/2025?

She purchased 66 Class A ordinary shares at $244.56 per share on 10/05/2025 under the Voluntary Equity Investment Program.

How many Accenture (ACN) shares does Katherine Lee Clifford own after this Form 4?

The filing reports she beneficially owns 4,821 shares following the reported transaction.

Was the purchase by Katherine Lee Clifford an open-market trade?

No. The filing states the purchase was made pursuant to the Accenture Voluntary Equity Investment Program, not an open-market transaction.

When was the Form 4 signed for this transaction?

The Form 4 was signed by an attorney-in-fact on 10/06/2025.

Does this Form 4 show any option exercises or derivative activity for ACN?

No. Table II for derivatives shows no entries; this Form 4 records only a non-derivative purchase of shares.